Dopamine acts, under appropriate conditions, as a selective neurotoxin
. This toxicity is attributed to the autoxidation of the neurotransmit
ter into a reactive quinone that covalently modifies cellular macromol
ecules (i.e. proteins and nucleic acids). The oxidation of the catecho
lamine to a quinone is greatly accelerated by the enzyme tyrosinase. T
here is controversy, however, as to whether or not tyrosinase is expre
ssed in human brain. In the present study, RT-PCR was utilized to demo
nstrate the presence of tyrosinase mRNA in post-mortem human brain tis
sues. Using gene-specific amplification primers, specific tyrosinase a
mplicons were detected following analysis of RNA from substantia nigra
of four individuals. Analysis of cerebellar RNA from the same individ
uals produced no amplification products. Control reactions performed i
n the absence of reverse transcriptase failed to generate PCR products
for any tissue tested. Three amplicons were subjected to direct DNA s
equencing and all proved to be identical with tyrosinase sequences, th
us obviating the possibility of amplification of a related gene. It is
clear, therefore, that the tyrosinase gene is expressed in the human
substantia nigra, lending support to previous studies describing tyros
inase-like activity and immunoreactive protein in the brain. This enzy
me could be central to dopamine neurotoxicity as well as contribute to
the neurodegeneration associated with Parkinson's disease.